登录

Innovision Med Closes Pre-A Round of Financing, Accelerating the Development of AI solutions in Gastroenterology

作者: Mailman 2021-01-12 02:15
影诺医疗
http://www.innovsight.com/
企业数据由 动脉橙 提供支持
辅助诊疗系统服务商 | 未公开 | 运营中
中国-福建
2023-02-16
融资金额:数千万人民币
元生创投
查看

According to VCBeat, Xiamen Innovision Medical Technology Co., Ltd. ("Innovision Med") announced the completion of the Pre-A funding round, led by China Prosperity Capital with participation from the existing investor DYEE Capital. Proceeds from this round will be mainly used for the R&D, phase III clinical trials, and marketing of products.


As a provider of AI-assisted diagnosis and treatment systems, Innovision Med is committed to applying deep learning technology to computer-aided diagnosis in medical imaging in gastroenterology and endoscopy departments, covering the whole process, multiple diseases, and all application scenarios. 


The AI-powered real-time auxiliary diagnosis system of digestive endoscopy, the core product of Yinnuo Medical, is featured with real-time analysis, accuracy and multi-scene application. At present, the system has been implemented in more than 60 first-class hospitals at grade 3 in more than 20 provinces and cities across China.


Talents are the first factor affecting the development of an enterprise. Hu Yanxing, the founder of Innovision Med, believes that the application of AI+ endoscope requires not only AI experts, but also medical experts in the field of endoscopy.


Since its establishment, Innovision Med has obtained a number of patents. In terms of products, the company builds a self-developed AI platform to connect the endoscopy and the endoscopic display, which is directly embedded into the existing clinical workflow and tries to fit the daily working process of the endoscopy room without changing the habits of doctors. Yinnuo Medical Artificial Intelligence Digestive Endoscopy Real-time Assisted Diagnosis System 


>>>>

About China Prosperity Capital


China Prosperity Capital was established in 2015 and headquartered in Shenzhen with offices in Beijing and Hong Kong. The company focuses on investing in the growth stage and mature companies in TMT, pan-entertainment, and other related sectors. It pays close attention to how the internet brings innovation to traditional business models and the change of people's lifestyle driven by technology advancement. 


>>>>

About DYEE Capital


DYEE Capital is a private equity & venture capital firm. Founded in June 2016, DYEE Capital focuses on modern services and investing in medical care, information services, consumption upgrading, and other fields.

相关赛道 医学影像
注:文中如果涉及企业数据,均由受访者向分析师提供并确认。
声明:动脉网所刊载内容之知识产权为动脉网及相关权利人专属所有或持有。转载请联系tg@vcbeat.net。

Mailman

医疗行业观察者

分享
动脉橙
以上数据来自动脉橙产业智库

我们以独创的在线数据库方式,为健康产业人士提供全方位和实时的市场资讯、行业数据和分析师见解。现已覆盖数字健康、医疗器械、生物医药等近500+细分赛道,涉及公司名单、招投标、投融资信息、头部企业动态等各类数据并持续更新。

点击 【申请试用】了解动脉橙产业智库更多内容。
精彩内容推荐

【首发】破解AI落地难题!慧维逆势融资数千万,产品已进百家医院

【首发】柏视医疗获A+轮融资,A轮融资规模达亿元,多管线布局赋能肿瘤精准治疗

潜心深耕心脑计算医学领域,阅影科技完成数亿元A+轮融资

​【首发】AI肿瘤治疗领头羊柏视医疗完成近亿元A轮融资,将进军智能外科手术赛道

Mailman

共发表文章3245篇

最近内容
  • 知之甚少:调研885名投资人后,原来美国VC们这样做决策

    2023-03-20

  • 辉瑞想要收购Seagen只是开始,这才是2023年并购的两大趋势

    2023-03-05

  • 【融资】核药企业Ratio再融资2000万美元,和拜耳合作研究新前列腺癌放射性疗法

    2023-02-09

上一篇

Onechip Bioelectronics Snares ¥10M in Series B from MatrixPartners China

2021-01-12
下一篇

亚心医院符竣:除了治病,医生也应满足人们对美好生活的憧憬【科室100人】

2021-01-12